Harvard Bioscience, Inc. Share Price & Technical Analysis

HBIO · $5.59 (+1.27%)

Healthcare / Medical Instruments & Supplies

AI Score 26 · Bearish

$5.59

+1.27%

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectroph

Price chart

Seasonality

May has 2 positive and 3 negative years (last 5 years shown)

-12% return in May, 3% avg return in past 3 year May month.

0% return in 2026, -24% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-24%22%-16%31%-12%0%
25-19%-51%-34%-39%27%-6%9%9%-12%16%43%-14%-71%
24-18%-2%-3%-10%-18%-12%12%-11%-5%-11%-8%-6%-92%
238%-4%50%36%1%-2%-16%-5%-3%2%-3%26%91%
22-17%-8%15%-16%-30%-1%4%-11%-22%4%-7%9%-80%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 26/100

Bearish · Downtrend · Neutral

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through websites and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic laboratories. It primarily sells its products under the Harvard Apparatus, Biochrom, BTX, HEKA, KD Scientific, MCS, Warner, DSI, Panlab, Hugo Sachs, and Buxco brands. Harvard Bioscience, Inc. was founded in 1901 and is based in Holliston, Massachusetts.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$26.61M

P/E ratio

52W high

$9.50

52W low

$2.80

Volume

23,086

Beta

1.57

Related stocks in Healthcare

Frequently asked questions

What is Harvard Bioscience, Inc. share price today?
Harvard Bioscience, Inc. (HBIO) last traded around $5.59 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does HBIO have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for HBIO. Download the app for real-time alerts.
How can I analyze Harvard Bioscience, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro